Does RISANKIZUMAB-RZAA Cause Fatigue? 2,483 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,483 reports of Fatigue have been filed in association with RISANKIZUMAB-RZAA. This represents 3.8% of all adverse event reports for RISANKIZUMAB-RZAA.
2,483
Reports of Fatigue with RISANKIZUMAB-RZAA
3.8%
of all RISANKIZUMAB-RZAA reports
4
Deaths
446
Hospitalizations
How Dangerous Is Fatigue From RISANKIZUMAB-RZAA?
Of the 2,483 reports, 4 (0.2%) resulted in death, 446 (18.0%) required hospitalization, and 9 (0.4%) were considered life-threatening.
Is Fatigue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 2,483 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
Headache (1,554)
What Other Drugs Cause Fatigue?
ADALIMUMAB (29,420)
LENALIDOMIDE (22,956)
ETANERCEPT (19,907)
METHOTREXATE (19,885)
RITUXIMAB (15,602)
PALBOCICLIB (15,190)
PREDNISONE (14,320)
TOCILIZUMAB (13,802)
TOFACITINIB (13,551)
INFLIXIMAB (13,473)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Fatigue Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA